European Society of Minimally Invasive Neurological Therapy (ESMINT) recommendations for optimal interventional neurovascular management in the COVID-19 era
Mohamed Aggour, Phil White, Zsolt Kulcsár, Jens Fiehler, Patrick A. Brouwer
Abstract
The Coronavirus Disease 2019 (COVID-19) pandemic began in December 2019 in Wuhan, China. The outbreak is due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Healthcare contamination and infection rates are thought to be very high (up to 29% in a recent Chinese publication1). These recommendations are not intended to overrule local official safety measures and guidelines but rather to give other insights and perspectives while facing this exceptional situation in the safest way possible for your patient, team, family and yourself.
Topics & Concepts
MedicineNeurovascular bundlePandemicCoronavirus disease 2019 (COVID-19)OutbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Intensive care medicine2019-20 coronavirus outbreakCoronavirusHealth careChinaDiseaseSurgeryPathologyInfectious disease (medical specialty)Economic growthLawEconomicsPolitical scienceLong-Term Effects of COVID-19COVID-19 and healthcare impactsRetinal and Optic Conditions